• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氢睾酮、R1881和R5020在正常、良性增生及癌性人前列腺细胞溶质中的结合

Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.

作者信息

Nozumi K, Sato R, Ito H, Maruoka M, Shimazaki J

出版信息

Urol Int. 1981;36(2):79-87. doi: 10.1159/000280398.

DOI:10.1159/000280398
PMID:6169181
Abstract

The binding of dihydrotestosterone, R 1881 and R 5020 was examined in cytosols of normal, benign hypertrophic and cancerous tissues of the human prostates. Almost all samples obtained by open operation showed high affinity binding to these ligands. Dissociation constants of the binding to these ligands were approximately 10(-9) M irrespective of the pathological state of the prostates. Maximum binding sites for dihydrotestosterone seemed to be greater in normal tissues than in the pathological ones. However, maximum binding sites for R 1881 and R 5020 were not significantly different among the normal and pathological prostates examined in the present study. Moreover, some correlation was observed between the maximum binding sites for R 1881 and those for R 5020. The samples resected by TUR seemed to be inadequate for analyses of androgen binding.

摘要

在人前列腺的正常组织、良性增生组织和癌组织的胞液中检测了双氢睾酮、R 1881和R 5020的结合情况。通过开放手术获取的几乎所有样本都显示出对这些配体的高亲和力结合。无论前列腺的病理状态如何,与这些配体结合的解离常数约为10(-9)M。双氢睾酮的最大结合位点在正常组织中似乎比病理组织中更多。然而,在本研究中检测的正常和病理前列腺组织中,R 1881和R 5020的最大结合位点没有显著差异。此外,观察到R 1881的最大结合位点与R 5020的最大结合位点之间存在一定相关性。经尿道前列腺切除术(TUR)切除的样本似乎不适合用于雄激素结合分析。

相似文献

1
Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.二氢睾酮、R1881和R5020在正常、良性增生及癌性人前列腺细胞溶质中的结合
Urol Int. 1981;36(2):79-87. doi: 10.1159/000280398.
2
Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
Endocrinol Jpn. 1981 Dec;28(6):725-34. doi: 10.1507/endocrj1954.28.725.
3
Androphilic proteins in the human prostate.
Prostate Suppl. 1981;1:9-17. doi: 10.1002/pros.2990020504.
4
Properties of progestin-binding protein in benign hypertrophic human prostate.人良性前列腺增生中孕激素结合蛋白的特性
Endocrinol Jpn. 1986 Jun;33(3):423-32. doi: 10.1507/endocrj1954.33.423.
5
[Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].[用于测定前列腺肿瘤和前列腺结节性增生中雄激素受体的天然配体与合成配体的比较]
Med Radiol (Mosk). 1983 Aug;28(8):13-6.
6
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
J Steroid Biochem. 1986 Sep;25(3):367-74. doi: 10.1016/0022-4731(86)90249-9.
7
Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.正常及增生性人类前列腺细胞质中的双氢睾酮结合蛋白,以及雌激素和抗雄激素对该结合的影响。
Endocrinol Jpn. 1977 Feb;24(1):9-14. doi: 10.1507/endocrj1954.24.9.
8
Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
Urol Int. 1986;41(2):133-8. doi: 10.1159/000281182.
9
Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.大鼠背外侧前列腺和邓宁R-3327前列腺腺癌细胞质中的雄激素受体结合特性。
Prostate. 1984;5(1):101-11. doi: 10.1002/pros.2990050110.
10
Assay of androgen binding sites by exchange with methyltrienolone (R 1881).通过与甲基三烯醇酮(R1881)交换来测定雄激素结合位点。
Steroids. 1976 Apr;27(4):497-507. doi: 10.1016/0039-128x(76)90084-2.

引用本文的文献

1
Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.晚期前列腺腺癌:生物学特性以及去势或促黄体生成素释放激素(LHRH)激动剂类似物所致雄激素剥夺的影响
Med Oncol Tumor Pharmacother. 1984;1(2):129-36. doi: 10.1007/BF02934985.
2
Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy.经尿道前列腺切除术和经膀胱腺瘤切除术获取的前列腺组织标本中的雄激素受体检测。
Urol Res. 1991;19(6):337-41. doi: 10.1007/BF00310146.